The binding of programmed death-1 (PD-1) to the surface of T cells and PD-1 ligand 1 (PD-L1) to tumor cells can prevent the immune-killing effect of T cells on tumor cells and promote the immune escape of tumor cells (Pang et al, 2023; Yi et al, 2022). This evidence concerns the gene CD274 and neoplasm.